Publication | Open Access

Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial

InflammationMetabolic SyndromeDiabetes ManagementAnti-inflammatorySystemic Glucocorticoid TherapyMetabolic DisorderMedicineDiabetesClinical TrialsPharmacotherapyPharmacologyMetabolic ComplicationsHealth Sciences